The study was conducted at a high-volume academic tertiary centre that specializes in the treatment of prosthetic joint infections, a complication that affects a small but meaningful fraction of the growing population of patients living with artificial joints. The researchers reviewed the records of 100 patients who underwent DAIR for acute infections of total hip replacements between 2008 and 2021, each with a minimum of two years of follow-up. Acute infections were defined using the 2018 criteria of the Musculoskeletal Infection Society, and included both infections occurring within six weeks of the original hip operation and sudden hematogenous infections, in which bacteria travel through the bloodstream and seed the implant after a symptom-free period. The average age of the patients was nearly 69 years, and more than half were women.

DAIR is the least invasive surgical option for an acute prosthetic joint infection. Rather than removing the entire implant — as required in single- or two-stage revision surgery — surgeons open the joint, thoroughly wash out the infected tissue with at least six litres of saline, exchange the modular components that bacteria can colonize, and then treat the patient with targeted antibiotics. Compared with full revision, DAIR carries less morbidity, costs less, and is technically simpler. But its Achilles heel is the biofilm: once bacteria have built a mature, protective layer on the metal and plastic surfaces of the implant, neither the immune system nor systemic antibiotics can reliably eradicate them, and the only cure is to remove the hardware entirely.

That biological reality is what makes timing so critical. Preclinical work has shown that immature Staphylococcus aureus biofilms can begin forming on implant surfaces as early as three hours after bacterial attachment, and that mature biofilms can develop within 24 hours. Although those laboratory timelines have not been directly translated to patients, they provide a sobering backdrop for the clinical data. Previous studies had already shown that in infected knee replacements, delays of more than 48 hours from admission to DAIR were associated with higher rates of septic reoperation and postoperative complications. In hip fracture care, too, surgery within 48 hours of admission is a well-established benchmark for reducing death and complications. What remained unknown was whether the same clock governed infected hip replacements.

The answer, according to the new analysis, appears to be yes. The mean time from hospital admission to DAIR in the cohort was 46.4 hours, with a wide spread ranging from 3 to 240 hours, and 27 percent of patients waited more than two days for surgery. Using multivariate regression to untangle the effects of age, health status, infection severity, and other variables, the researchers found that each additional hour of delay from admission to the operating room was associated with roughly a 2 percent increase in the odds of death within 90 days — an odds ratio of 1.02 with a confidence interval of 1.00 to 1.03 and a p-value of 0.04. Notably, the time from the onset of symptoms to surgery showed no significant relationship with any outcome, a finding the authors attribute to the inherent subjectivity and unreliability of patient-reported symptom timelines.

The study also identified other, less modifiable risk factors that shaped patient fates. Increasing age raised the risk of death within one year, with each additional year of life corresponding to a 6 percent increase in odds. Patients classified as McPherson host grade C — those with the poorest overall systemic health — faced dramatically elevated risks compared with grade A patients: a nearly thirteenfold increase in one-year mortality and a more than sevenfold increase in postoperative complications. Low preoperative haemoglobin emerged as a significant predictor of reoperation, with each gram-per-litre decrease raising the odds by about 4 percent. The severity of the local extremity condition also mattered, with grade II extremities carrying more than three times the risk of complications compared with grade I.

The raw outcomes of the cohort were sobering. Just over half of the patients — 52 percent — eventually required reoperation for stubborn infection that DAIR could not cure, and patients averaged 1.5 additional hip surgeries after the initial procedure. Thirty percent were readmitted within 90 days, and mortality reached 3 percent at 30 days, 6 percent at 90 days, and 12 percent at one year. Nearly 70 percent experienced postoperative complications, the vast majority of them severe enough to require surgical intervention. The authors caution that their centre is a regional referral hub for the most complex prosthetic joint infections, which likely inflates these failure rates compared with the 58 to 78 percent success rates reported in broader literature. Indeed, 89 percent of the cohort carried an ASA classification of III or IV, indicating severe systemic disease, and the average body mass index of 31 placed most patients in the obese category.

The microbiology added another layer of complexity. Intraoperative cultures revealed a high prevalence of difficult-to-treat pathogens, including polymicrobial infections, methicillin-resistant Staphylococcus aureus, and gram-negative organisms such as Enterococcus, Klebsiella, Enterobacter, and E. coli. Among the patients who died within a year, a quarter had polymicrobial cultures, and Enterococcus and Enterobacter species each appeared in nearly 17 percent of cases — consistent with prior research linking Enterococcus infections after hip replacement to increased mortality. Antibiotic therapy itself was a long haul: the mean initial regimen lasted 37 days, 42 percent of patients required chronic suppressive antibiotics afterwards, and the total antimicrobial exposure averaged more than 333 days per patient. Interestingly, delays beyond 48 hours did not prolong antibiotic courses, suggesting that the harm of waiting manifests through biology rather than through treatment intensity.

Perhaps the most actionable part of the study is its dissection of why delays happen. The mean time from admission to DAIR was about 6.6 hours longer than in a comparable knee infection cohort from the same institution, and the reasons for the longest delays included operating room availability, the need to optimize medical comorbidities, and the management of anticoagulant medications. Many of these barriers are modifiable. Patients on direct oral anticoagulants or warfarin typically wait days for their blood to thin back to a safe range, but reversal agents could be deployed earlier in time-critical infections. Surgeon availability and familiarity with the procedure also contributed, pointing to the value of streamlined protocols, better resource allocation, and clear institutional pathways to the operating suite.

The authors are careful to acknowledge the limits of their work. The retrospective design introduces selection bias, the single-centre cohort of 100 patients produced wide confidence intervals for some estimates, and the 13-year study window spanned changes in electronic records, surgical technique, and implant technology. The study also could not define a precise cutoff — such as the 48-hour benchmark established in knee and hip fracture care — beyond which outcomes deteriorate. Still, the central message is difficult to ignore: in infected hip replacements, the time between admission and surgery is an objective, measurable, and modifiable factor tied to survival. For hospitals, the implication is that prosthetic joint infections deserve the same urgency as hip fractures, with rapid access to the operating room treated not as a convenience but as a clinical imperative. For patients and their families, the takeaway is simpler still — when an artificial joint becomes infected, hours matter.

Subject of Research: The effect of timing from hospital admission to DAIR surgery on mortality and outcomes in acute total hip prosthetic joint infections

Article Title: Timing from admission to debridement, antibiotic, and implant retention (DAIR) affects mortality risk in total hip prosthetic joint infections

Article References: Legler, J., Morgan, S., Beaulé, P., Abdelbary, H., Grammatopoulos, G., & Garceau, S. (2026). Timing from admission to debridement, antibiotic, and implant retention (DAIR) affects mortality risk in total hip prosthetic joint infections. Journal of Bone and Joint Infection, 11(4), 463-477. https://doi.org/10.5194/jbji-11-463-2026

Image Credits: AI Generated

DOI: 10.5194/jbji-11-463-2026

Keywords: prosthetic joint infection, total hip arthroplasty, DAIR, surgical timing, mortality, biofilm, debridement, antibiotics, implant retention, reoperation, orthopaedic surgery, tertiary referral centre

The scale of the underlying problem is set to grow. The annual number of total hip arthroplasties is projected to rise substantially over the coming decades, driven by population growth and increasing utilization. Although revision rates per implant have gradually declined thanks to better bearing surfaces and fixation, the absolute number of revision procedures continues to climb. Meanwhile, the true incidence of both major complications is likely underestimated. Joint registries capture only fractures requiring stem revision, yet more than half of periprosthetic femoral fractures are treated without stem revision, yielding an estimated true incidence of 0.92 per 1000 prosthesis years. Infection figures suffer from incomplete reporting and failure to update preoperative diagnoses with intraoperative culture results. With an ageing, increasingly comorbid population living longer with prosthetic joints, the absolute burden of both complications is expected to increase sharply.

The coexistence of the two conditions is rarer still, and the authors stress a crucial distinction: a fracture occurring around a chronically infected implant is fundamentally different from an acute infection developing after fracture-fixation surgery. Chronic infection involves a mature biofilm on the implant surface, a microbial fortress that antibiotics alone cannot penetrate, and typically arises in the setting of longstanding infection and septic loosening. Because implant loosening is a well-established risk factor for periprosthetic fracture, septic loosening may further increase fracture susceptibility, although robust data on this relationship remain limited. Existing evidence-based guidelines cover fractures, joint infection, and fracture-related infection separately, but integrating fracture stabilization, infection eradication, and definitive reconstruction in often frail patients has remained an unsolved challenge.

The first patient, a 74-year-old woman with multiple comorbidities, had undergone hip replacement in 2019 for a femoral neck fracture, followed by an Escherichia coli joint infection treated with repeated surgeries, and then presented in 2022 after a low-energy fall. Imaging showed a Vancouver type C fracture around a loosened cemented stem. Fluoroscopy-guided hip aspiration revealed a synovial white blood cell count of 15,880 cells per microliter with 97 percent neutrophils and a positive alpha-defensin test, meeting European Bone and Joint Infection Society criteria for infection; cultures confirmed methicillin-resistant Staphylococcus epidermidis. After multidisciplinary discussion and shared decision-making, the team proceeded with a two-stage revision.

The first stage follows a disciplined dirty-then-clean logic. In the dirty phase, surgeons explant the prosthesis through an extensile approach, perform thorough debridement and lavage, and remove infected tissue and foreign material. In the clean phase, the fracture is stabilized, here with cerclage wiring and a plate-screw construct, and a custom-made antibiotic-loaded cement spacer is implanted to bridge the fracture and deliver high local antibiotic concentrations. For this patient, the spacer was lengthened from a prefabricated device and loaded with meropenem because of her history of ESBL-producing E. coli. Targeted antibiotics were de-escalated to oral minocycline, wounds healed uneventfully, and C-reactive protein normalized. Ten weeks later, the second stage removed the spacer and hardware, confirmed healthy tissues and fracture healing, applied fresh plate fixation to reinforce the femur, and implanted a definitive cemented stem with a dual mobility cup. Three and a half years on, imaging showed complete healing, infection markers stayed normal, and the patient reported better mobility than before her fall.

The second case illustrates how unpredictable these scenarios become. A 56-year-old man with a history of hip resurfacing, early infection, and a two-stage revision for Staphylococcus aureus and Pseudomonas aeruginosa sustained a fracture whose plate fixation failed through non-union. At referral, his synovial fluid showed 59,800 white cells per microliter with 99 percent neutrophils, though cultures were negative, likely suppressed by ongoing antibiotics from the referring hospital. During the first stage, surgeons encountered frank pus along the plate and in the joint; the stem was so well fixed that extraction required an extended trochanteric osteotomy, a controlled cut of the greater trochanter to gain access. Cultures grew P. aeruginosa, treated with eight weeks of oral levofloxacin. At the second stage, with the fracture and osteotomy not yet healed, a new plate construct and a modular revision stem were implanted, but six samples unexpectedly grew Candida albicans, prompting six months of fluconazole alongside the antibacterial course. Two years later, radiographs and CT showed complete healing and normalized inflammatory markers, although patient-reported outcome measures remained poor, a sobering reminder that eradication does not guarantee subjective recovery in complex, comorbid patients.

The third patient, a 76-year-old woman, presented with a draining skin fistula over her anterior incision and a Vancouver B2 fracture after a fall. The fistula was traced and excised down to the implant, the prosthesis was explanted, and the fracture stabilized with a plate extending to the trochanter plus a long antibiotic spacer. Cultures identified Cutibacterium avidum, a slow-growing skin bacterium, treated with oral amoxicillin. Eight weeks after the first stage, all second-stage cultures were negative, a new plate and an uncemented dual mobility cup with a modular fluted titanium revision stem were implanted, and the patient completed twelve weeks of total antibiotic therapy. Seven months after reimplantation she reported no problems, and her patient-reported scores were essentially perfect across pain, symptoms, activities, functioning, and quality of life.

Beyond the outcomes, the paper distills hard-won technical lessons. Diagnosing infection amid a fracture is treacherous: hemarthrosis and local inflammation can produce false-positive synovial white cell counts, especially when the fracture extends into the joint, so the authors reserve the first milliliter of aspirate for cell analysis to minimize blood contamination, and note that molecular diagnostics can add value. Timing matters too: recent studies found no clear correlation between the interval from trauma to definitive surgery and outcomes, including mortality, so postponing surgery until an experienced revision and septic-surgery team is available appears safe. Fracture-related infection principles demand stable fixation that preserves bone biology, and the authors advise leaving spare screw holes or using the shortest adequate plate at the first stage to preserve options for reconstruction. Surgeons must also consider adjacent prosthetic joints, since metachronous infection of a same-side knee replacement has been reported in up to 20 percent of cases.

The interval between stages must be individualized, balancing the risk of septic failure against premature reimplantation compromising fracture healing. The team generally targets a window of roughly six weeks without an antibiotic-free interval, extended when fracture healing needs more time, and weighs wound status, C-reactive protein trends, spacer tolerance, and acetabular erosion. Conceptually, they treat the second stage as a single-stage exchange of the spacer, replacing all components including the first-stage plate, reasoning that organisms introduced during the long first procedure may not have been covered by targeted therapy, and that plate exchange is straightforward once the fracture is reduced and partially healed. The authors acknowledge the limits of their evidence: three heterogeneous patients, no control group, and a framework grounded in expert opinion. They call on large musculoskeletal infection centers to build prospective databases and on international societies to forge consensus algorithms. For now, their framework offers surgeons confronting this rare collision of broken bone and entrenched biofilm a tested, reproducible path through it.

Subject of Research: Two-stage surgical management of periprosthetic femoral fractures around chronically infected total hip arthroplasties

Article Title: Periprosthetic fractures around chronically infected total hip arthroplasties: a case series and pragmatic two-stage treatment framework

Article References: Vles, G. F., Metsemakers, W.-J., Aerden, L., Geurts, J., Borens, O., & Ghijselings, S. (2026). Periprosthetic fractures around chronically infected total hip arthroplasties: a case series and pragmatic two-stage treatment framework. Journal of Bone and Joint Infection, 11(4), 547-554. https://doi.org/10.5194/jbji-11-547-2026

Image Credits: AI Generated

DOI: 10.5194/jbji-11-547-2026

Keywords: periprosthetic fracture, periprosthetic joint infection, total hip arthroplasty, two-stage revision, antibiotic-loaded cement spacer, biofilm, fracture-related infection, septic loosening, revision stem, orthopaedic surgery, case series, debridement

Necrotizing fasciitis is among the most feared infections in medicine. It attacks the fascia, the connective tissue sheath that wraps around muscles and organs beneath the skin, and spreads along these planes with alarming speed. As bacteria multiply, they release toxins that destroy tissue, cut off blood supply, and can drive the body into septic shock. Mortality estimates cited in the report reach 18.1 percent overall, and when the infection takes hold in the hand, the stakes are uniquely high: a systematic review of hand-originating necrotizing fasciitis reports a mortality rate of around 8 percent and an amputation rate of 28 percent. The thumb, which accounts for roughly 40 percent of overall hand function, is an exceptionally rare site for the disease, with only a handful of cases documented in the medical literature.

The patient in this report arrived at the emergency department after first seeking care elsewhere, where clinicians drained what appeared to be a simple abscess. Instead of resolving, his symptoms worsened rapidly. He was newly diagnosed with type 2 diabetes, a critical detail, because diabetes impairs immune defenses and tissue integrity, making patients far more vulnerable to aggressive infections. On examination, surgeons found blackened, necrotic tissue in the thumb pulp with pus discharge, marked swelling across the entire hand, bluish skin discoloration, and a sinister finding: palpable crepitus, the crackling sensation produced by gas trapped under the skin. He could not flex his thumb at all, and the tenderness had spread to his wrist and forearm.

Diagnostic imaging confirmed the surgeons’ worst suspicions. An X-ray of the left hand revealed marked soft-tissue swelling and multiple pockets of air over the thenar eminence, the muscular pad at the base of the thumb, a hallmark of a gas-forming infection. Laboratory tests painted a picture of overwhelming systemic inflammation: his white blood cell count had soared to 28.7 × 10³ per microliter, and his procalcitonin level, a marker of severe bacterial infection, stood at 3.28 nanograms per milliliter. He was immediately started on a triple-antibiotic regimen of intravenous clindamycin, vancomycin, and piperacillin-tazobactam, and taken to the operating room the following morning for emergency incision, drainage, and debridement.

What surgeons found in the operating room underscored how deceptively mild these infections can appear from the outside. The hand was tense and swollen, the thumb tip was dead, and deep within the tissues lay extensive necrosis, foul-smelling brown pus, and thrombosed dorsal veins. Surgeons made multiple incisions to evacuate the infection and performed a carpal tunnel release to decompress the median nerve, irrigating the wound with hydrogen peroxide, Betadine, and saline. By the next day, the disease had progressed relentlessly. The thumb was disarticulated at the metacarpophalangeal joint, and surgeons excised all necrotic tissue, including dead extensor tendons and flexor sheaths, until they reached healthy margins. Tissue cultures identified a polymicrobial cocktail: Streptococcus constellatus, Streptococcus agalactiae, and anaerobic bacteria, consistent with Type 1 necrotizing fasciitis.

With the infection controlled and the wound bed confirmed viable, the reconstruction phase began four days after the amputation. The team selected a free anterolateral thigh flap, a workhorse of modern reconstructive surgery. This technique involves harvesting a large paddle of skin, fat, and fascia from the patient’s thigh, along with its feeding artery and veins, then transplanting it to the hand and reconnecting the vessels under a microscope. In this case, the flap’s artery was anastomosed to the radial artery and its accompanying veins, restoring blood flow to the reconstructed tissue. The surgeons deliberately chose a fasciocutaneous flap over a muscle flap because it provides bulk while remaining easier to dissect in a planned second stage, and they preserved a backup flap option on the opposite side in case the transplant failed. They also harvested the flexor tendon from the patient’s index finger to reconstruct the destroyed extensor tendon of the thumb, and stabilized the first metacarpal with K-wires.

Recovery was not linear. Thirteen days after the initial presentation, persistent pus drainage and spreading necrosis forced yet another operation. A four-by-four-centimeter patch of skin on the volar forearm had died, even though the thigh flap itself remained healthy and well-perfused. Surgeons responded with a second, elegantly different technique: a distally based pedicled ulnar artery perforator flap. Unlike a free flap, this tissue is rotated locally from the forearm while remaining attached to its ulnar artery blood supply, avoiding the need for microvascular anastomosis in an already compromised field. The donor site was covered with split-thickness skin grafts from the thigh. Intraoperative cultures from this second procedure were negative, a sign the infection had finally been eradicated.

The patient spent 34 days in the hospital, during which his glycemic control was tightly managed and his inflammatory markers steadily normalized, with white blood cells falling to 11.0 × 10³ per microliter by discharge. Occupational therapy began early, with gentle passive wrist flexion and composite digital stretching exercises once the splint was removed. At follow-up visits every three days, both the thigh donor site and the hand recipient site healed well, the flaps remained viable, and finger range of motion continued to improve. The authors report no postoperative complications and favorable recovery through six months of follow-up, though they note that definitive reconstruction has been deferred because the patient has hesitated to proceed.

The surgical team’s discussion of the case offers broader lessons for clinicians. Necrotizing fasciitis of the thumb often begins with subtle symptoms, redness, induration, and pain, that can escalate within hours to days. Reported cases in the literature range from fulminant progression within 8 to 24 hours to slower courses unfolding over four days, as in this patient. The key diagnostic clue is pain disproportionate to physical findings, and the authors argue clinicians should maintain a low threshold for suspecting the disease, especially in diabetic or immunocompromised patients, because the infection can look localized and mild on the surface while ravaging deep tissues. Current guidelines, including those from the Eastern Association for the Surgery of Trauma, emphasize debridement within 24 hours of diagnosis, empiric broad-spectrum antibiotics covering both aerobic and anaerobic organisms, and supportive sepsis care.

The case also illuminates the future of thumb reconstruction. Because microsurgical reconstruction in an actively infected field carries a high risk of failure, the team deferred definitive restoration until the infection fully resolved and the soft-tissue envelope matured. The planned next stage is a toe-to-hand transfer, in which part of the patient’s great toe, with its bone, joint, tendon, and nerve supply, is transplanted to recreate the missing thumb, an approach supported by recent evidence showing high functional success in staged thumb reconstruction. For now, the man retains a healed, functional hand where a flesh-eating infection threatened to take far more than a single digit, a testament to aggressive surgery, multidisciplinary care, and the remarkable toolkit of modern reconstructive microsurgery.

Subject of Research: Necrotizing fasciitis of the thumb and its staged microsurgical reconstruction with free and pedicled flaps

Article Title: Necrotizing fasciitis of the thumb reconstructed with a free flap: a case report and review of surgical lessons

Article References: Necrotizing fasciitis of the thumb reconstructed with a free flap: a case report and review of surgical lessons. (n.d.). https://doi.org/10.1186/s44452-026-00014-y

Image Credits: AI Generated

DOI: 10.1186/s44452-026-00014-y

Keywords: necrotizing fasciitis, thumb amputation, free flap reconstruction, anterolateral thigh flap, microsurgery, diabetes, polymicrobial infection, debridement, hand surgery, Streptococcus constellatus, toe-to-hand transfer, reconstructive surgery

Osteomyelitis of the foot is a familiar adversary in medicine, particularly among patients with diabetes and peripheral neuropathy, where loss of protective sensation allows small wounds to deepen unnoticed until bacteria reach bone. The standard playbook combines targeted antibiotics with surgical removal of infected bone, an approach widely accepted as effective for most cases of diabetic foot osteomyelitis. But the operation itself is only the opening act. Wound care after amputation remains one of the most deceptively difficult phases of treatment, because the surgeon is working with tissue that is already infected, poorly perfused, and dependent on a patient’s long-term cooperation. In this case, the toe was amputated at a secondary hospital, yet the story took a turn that clinicians see all too often: after seven days of hospitalization, dissatisfied with the service and the wound dressing care he was receiving, the patient discharged himself against medical advice.

Several days later he arrived at an outpatient clinic with an oozing wound at the amputation stump. Examination revealed loss of the cutaneous layer, with swollen subcutaneous tissue exposed to the air. Encouragingly, his white blood cell count and C-reactive protein levels were within normal limits, no microbial growth was identified in cultures, and no peripheral necrosis or vascular disease was detected. The wound was not systemically infected. But it refused to dry. The volume of exudate did not decrease, and a transparent yellow discharge, suspicious for synovial fluid leaking from the disrupted joint, persisted day after day. That detail mattered enormously. A dehisced stump with no protective skin barrier, sitting over a joint capsule that might be leaking synovial fluid, is an open invitation for bacteria to colonize the wound and seed the deeper structures. The treating team concluded that flap reconstruction was indispensable, not merely to close a hole but to rebuild the biological wall separating the outside world from the joint.

The operation they chose was the Limberg flap, also known as a rhomboid flap, a workhorse of reconstructive surgery first described decades ago and still prized for its elegant geometry. The technique recruits a diamond-shaped segment of adjacent healthy skin and subcutaneous tissue, transposes it across a pivot point, and uses the laxity of surrounding skin to fill the defect while distributing mechanical tension along the closure lines. Here, the surgeons first performed a rhomboid-shaped debridement, excising necrotic and swollen tissue to leave a clean 3.5 by 3.5 centimeter defect, then raised the Limberg flap with its pivot point at the medial side of the proximal phalanx stump. The geometry was constrained by the previous surgery and the scarcity of healthy adjacent tissue, meaning that mechanical tension on the flap was unavoidable, a compromise the team accepted because no better local option existed.

Perioperative care was built to protect the fragile reconstruction. The patient received a prophylactic first-generation cephalosporin to guard against infection, a prostaglandin E1 analogue to promote vasodilation, and antiplatelet therapy to enhance blood supply to the flap, a rational combination given that microvascular perfusion determines whether transferred skin lives or dies. In the immediate aftermath, the strategy appeared to work. Exudate dropped markedly, and the suspicious synovial fluid leakage stopped entirely, confirming that the flap had successfully sealed the joint. One week after surgery, however, mild edematous changes appeared in the flap, and the tissue eventually became necrotic. The reconstruction had partially failed, a consequence of the tension under which it was placed and the compromised local conditions.

What happened next is arguably the most instructive part of the case. Rather than rushing back to the operating room for another flap or a skin graft, the team pivoted to conservative management: daily dressing changes with intermittent debridement of the necrotic material. Although the skin flap did not fully survive, it continued to serve as a physical barrier and provided structural support to the adjacent tissue, promoting recovery and the formation of healthy granulation tissue beneath it. Over the following two months, healthy tissue gradually covered the lesion, and the wound healed by secondary intention. The authors point out that this outcome echoes a concept recognized in the literature, in which even a failed flap can function as a biological dressing, reducing contamination and inflammation and facilitating the development of healthy tissue before any subsequent grafting. In other words, a partially necrotic flap is not always a wasted operation; sometimes it is scaffolding.

The case also shines a light on how often amputation wounds go wrong in broader populations. Stump-related complications are dominated by wound infection and poor healing, which account for roughly 70 percent of problems, followed by poorly fashioned stumps at 20 percent and phantom pain at 10 percent. Research has linked smoking to both immediate and late complications, preoperative infection to immediate and intermediate complications, and amputations performed for peripheral vascular disease or trauma to late complications. One study of 739 patients who underwent lower-limb amputation found that 8.3 percent were readmitted within 30 days because of stump-related complications, and 61 percent of those complications required surgical intervention, with readmission rates of 35.9 percent after above-knee amputation and 68.7 percent after below-knee amputation. In the present patient, the authors suggest that both his smoking history and the underlying osteomyelitis likely contributed to the wound breakdown, and they note that pre-emptive vascular examinations to identify peripheral vascular disorders would have aided wound care planning from the start.

The report also engages with a genuine technical controversy in modern wound care: the use of topical negative pressure therapy, or TNP, in which vacuum sealing drainage systems actively draw fluid from a wound to promote granulation. While TNP has advanced the management of soft-tissue defects and amputation wounds, its application over open joints remains contested, with variable reported outcomes. In this case, the authors argue that applying negative pressure directly to the wound could have caused excessive drainage of synovial fluid and potential joint disruption. Their proposed sequence for similar situations is therefore deliberate: flap reconstruction first, to close the joint and reestablish the skin barrier, followed by TNP dressing only afterward, once the joint is protected. This ordering, they suggest, captures the benefits of vacuum therapy without exposing a leaking joint to its risks.

Perhaps the most sobering threads running through the case are the ones that have nothing to do with surgical technique. The patient’s poor sanitary conditions, his ingrown toenails, his self-discharge against medical advice, and his refusal to return to the hospital where the amputation was performed all shaped the clinical course as powerfully as any incision. The authors emphasize that understanding patient needs and providing clear explanations of wound status at every visit are essential for building trust, and that consistent wound care until complete recovery is non-negotiable, yet the high cost of treatment often limits access to appropriate care. This patient was a type I medical aid recipient in South Korea, with his basic wound care almost fully covered by government support, a fact the authors credit with making the prolonged dressing regimen feasible. They call for greater coordination among healthcare systems, insurance providers, and government assistance programs to reduce the burden of medical poverty, arguing that patient compliance, trust in clinicians, and financial support together determine whether complicated wounds heal. The case, prepared in accordance with the SCARE reporting criteria, ultimately delivers a double lesson: a well-executed Limberg flap can rescue a failing amputation stump even when the flap itself partially dies, but surgery is only one pillar of recovery, and the quieter work of daily dressings, repeated debridement, and sustained patient engagement is what carries the wound across the finish line.

Subject of Research: Management of a complicated post-amputation stump wound using Limberg flap reconstruction and persistent wound care following toe osteomyelitis

Article Title: Complicated post-amputation stump wound managed with a Limberg flap and persistent wound care: a case report

Article References: Complicated post-amputation stump wound managed with a Limberg flap and persistent wound care: a case report. (n.d.). https://doi.org/10.1186/s44452-026-00028-6

Image Credits: AI Generated

DOI: 10.1186/s44452-026-00028-6

Keywords: osteomyelitis, amputation, Limberg flap, wound care, flap reconstruction, debridement, stump complications, topical negative pressure, patient compliance, diabetic foot, reconstructive surgery, synovial fluid leakage